Shares of Bluebird Bio (NASDAQ: BLUE) are up over 10% today after the United States Food and Drug Administration (FDA) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE